Bruno Lapauw is a Professor and head of the Department of Endocrinology at the Ghent University Hospital, Belgium. He earned his Ph.D. degree in 2009. He now supervises the Unit for Osteoporosis and Metabolic Bone Diseases at the Ghent University Hospital. He has specialized in general endocrinology, (hereditary) endocrine oncology, pituitary disorders, osteoporosis metabolic bone diseases, and disorders of calcium and phosphate metabolism. Current research focuses on the clinical, hormonal, and genetic determination of bone metabolism in men and the relation between bone and substrate metabolism. He was the award winner of the ECTS/Amgen Bone Biology Fellowship in 2016. He is a member of the European Society of Endocrinology (ESE), Endocrine Society (ES), American Society for Bone and Mineral Research (ASBMR), European Calcified Tissue Society (ECTS), Belgian Endocrine Society (BES), Belgian Thyroid Club, Belgian Bone club and Belgian Nutrition Society (BNS).
Serge Rozenberg is a Clinical Professor of Obstetrics and Gynaecology at the Free University of Brussels, Belgium. He is in charge of the menopause and osteoporosis unit at the University Hospital, St Peter, and is well-recognized in women's health in general. He has written a thesis on postmenopausal osteoporosis and published more than 100 articles in international peer-reviewed journals on topics such as women's health, menopause, osteoporosis, and reproductive endocrinology. He is on the editorial board of several international journals and has received several awards and grants for his research. He is currently also the secretary of EMAS and one of the editors of Maturitas.
Jean-Jacques Body is an internist, an endocrinologist, and has been a medical oncologist. He is now an invited Professor (ULB), a Consultant at University Hospital Brugmann (ULB), CHIREC, and Professor Emeritus since March 2017. He was until then Full Professor of Internal Medicine at ULB and Head of the Department of Medicine at University Hospital Brugmann in Brussels. He was previously Head of the Internal Medicine Clinic at Institute J. Bordet, the Cancer Center of ULB. He received his training at the “Université Libre de Bruxelles” (ULB, Brussels, Belgium) and the Mayo Clinic. He has been a regular member of the “Committee of Scientific Advisors” of “The International Osteoporosis Foundation (IOF)” since 2012. He has been Chairman of the “Clinical Practice Action” Group of “The European Calcified Tissue Society” (ECTS) from 2019 until early 2023. He has been President of the “Belgian Bone Club” for many years and he is a member of several professional organizations, including ASBMR, Endocrine Society, ECTS, and MASCC. He has recently been nominated Fellow of the ASBMR (it is the first time this distinction has been granted to a Belgian scientist or clinician). He has been the Founder and first President of “Groupe Européen d’Etudes des Métastases Osseuses” (GEMO). He has authored or co-authored more than 320 international peer-reviewed papers and he counts more than 200 invited lectures at international meetings.
Evelien Gielen is an associate professor at the Faculty of Medicine at KU Leuven, where she received her training in Internal Medicine and Geriatrics. She also followed an Advanced Postgraduate Course in Geriatric Medicine at the European Academy for Medicine of Ageing (EAMA). In 2014, she obtained her PhD at KU Leuven. She is deputy Head of the Clinic at the Geriatric department and supervisor at the Centre for Metabolic Bone Diseases in UZ Leuven. She is involved in several (inter)national scientific projects and working groups in the field of age-related osteoporosis and sarcopenia. Her main research activities focus on strategies to promote healthy aging and reduce fracture risk in older persons. She received funding from the Research Foundation Flanders (FWO) for both research projects on the effects of personalized non-pharmacological interventions for persons with sarcopenia and on the role of gut microbiota in the development and treatment of sarcopenia. She has been a board member of the Belgian Bone Club (BBC) since 2014 and became the current president in 2019. She also is one of the founders and the current treasurer of the Belgian Aging Muscle Society (BAMS) as well as a member of the European Calcified Tissue Society (ECTS), the Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD), and the Belgian Society of Gerontology and Geriatrics (BSGG).
Etienne Cavalier is currently a Professor of Clinical Chemistry at the University of Liege and Head of the Department of Clinical Chemistry at the University Hospital of Liege (CHU de Liège). He graduated with as Master's in Pharmaceutical Sciences in 1994 and an Advanced Master in Clinical Biology in 1999 from the University of Liege (Belgium), which allowed him to be recognized as a European Specialist in Laboratory Medicine (EuSpLM). In 2010, he obtained his PhD thesis at the University of Liege. His current research topics are bone markers, vitamin D, PTH, vascular calcification markers, markers of acute kidney diseases, glomerular filtration rate (estimation, biomarkers), markers of frailty and sarcopenia, LC-MS/MS methods for steroids and peptides quantification. He is the actual President of the Royal Belgian Society of Laboratory Medicine and is the Chairman of the IFCC-IOF Committee for Bone Markers. He is also a member of the Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and of the Belgian Bone Club. He is a member of the scientific advisory board of the International Osteoporosis Foundation (IOF) and ESCEO as well as a member of various Societies of Clinical Chemistry, Nephrology, and Endocrinology.
